Home People Yambazi Banda

Yambazi Banda

Yambazi Banda, Ph.D., is the Head of Platform at ChronicleBio, a data-driven biotechnology company applying multi-omics and artificial intelligence to decode chronic disease. Banda is a computational biology leader whose career spans particle physics at Oxford to leading population-scale genomics at UCSF and Ancestry.com. He brings a rare combination of statistical rigor, computational depth, and translational experience to the platform.

Education & Academic Background

A Rhodes Scholar, Banda holds a D.Phil. in Particle Physics from Oxford. His academic contributions include serving as first author of a population structure paper examining the relationship between genetic ancestry and how people self-identify. Banda is a co-author on publications in the New England Journal of Medicine addressing genetic diversity and health disparities in STEM fields.

Career History

  • Head of Platform, ChronicleBio (2025-present)
  • Executive Director, Spectrum Biobank, a non-profit dedicated to closing the genetic data diversity gap
  • Director, Ambys Medicines, overseeing NGS pipeline development in the gene and cell therapy space
  • Senior roles at Ancestry.com leading population genetics algorithm development and FDA 510(k) statistical submissions
  • Postdoctoral researcher, UCSF

What Yambazi Banda could bring to Head of Platform at ChronicleBio: Banda's unique combination of foundational physics training, population-scale genomics expertise, and translational medicine experience positions him to architect a platform capable of mechanistic patient stratification in chronic disease. His track record leading large-scale genomics projects at UCSF (including the 100,000-subject GERA cohort) and FDA regulatory experience at Ancestry, combined with his demonstrated commitment to genetic diversity and scientific inclusivity through Spectrum Biobank, suggests he will bring both technical rigor and an equity-focused approach to ChronicleBio's efforts to decode neuroimmune conditions and end trial-and-error medicine.

This is an automatically generated Light profile created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.

Facts compiled by Executive Moves from publicly available news and press releases on 12 June 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.

To upgrade to a Premium Profile reach out to us at info@executive-moves.com.

Light profile · auto-generated

Are you Yambazi Banda?

This is a Light profile, auto-generated from public news coverage. Claim it to verify your bio, add a photo and links, and control how your career is represented on Executive Moves.

Claim this profile →